Contineum Therapeutics’ M1 receptor antagonist has failed to move the needle in a phase 2 vision test for patients with a common form of multiple sclerosis. The Johnson & Johnson-partnered asset, ...
Medication is not always necessary or the best choice for treating a vision problem, and sometimes, medication isn't an option at all. But in many cases, it can certainly help with vision problems, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results